CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,000 | -34.2% | 61,093 | -0.8% | 0.01% | -33.3% |
| Q2 2022 | $111,000 | -10.5% | 61,571 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $124,000 | +72.2% | 61,571 | +131.7% | 0.01% | +80.0% |
| Q4 2021 | $72,000 | -37.4% | 26,571 | +3.1% | 0.01% | -50.0% |
| Q3 2021 | $115,000 | -22.8% | 25,771 | 0.0% | 0.01% | -23.1% |
| Q2 2021 | $149,000 | -15.3% | 25,771 | +3.1% | 0.01% | -27.8% |
| Q1 2021 | $176,000 | +363.2% | 25,000 | +3334.1% | 0.02% | +28.6% |
| Q1 2018 | $38,000 | -19.1% | 728 | +4.3% | 0.01% | -22.2% |
| Q4 2017 | $47,000 | -19.0% | 698 | 0.0% | 0.02% | -5.3% |
| Q3 2017 | $58,000 | -20.5% | 698 | -98.9% | 0.02% | +216.7% |
| Q3 2011 | $73,000 | – | 61,093 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |